GlobeNewswire: News from Pennsylvania Contains the last 10 of 39880 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T08:01:07ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2024/03/27/2853632/0/en/Neuronetics-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html?f=22&fvtc=8&fvtv=PennsylvaniaNeuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)2024-03-27T20:30:00Z<![CDATA[MALVERN, Pa., March 27, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced the granting of inducement awards of Restricted Stock Units representing a total of 135,000 shares of the Company’s common stock (RSUs) to eleven new non-executive employees. In accordance with NASDAQ Listing Rule 5635(c)(4), these awards were approved by Neuronetics’ Compensation Committee and made as material inducements to their respective employment with the Company.]]>https://www.globenewswire.com/news-release/2024/03/27/2853625/0/en/Orchestra-BioMed-Reports-Full-Year-2023-Financial-Results-and-Provides-Fourth-Quarter-Business-Update.html?f=22&fvtc=8&fvtv=PennsylvaniaOrchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update2024-03-27T20:17:23Z<![CDATA[NEW HOPE, Pa., March 27, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its full year 2023 financial results and provided a fourth quarter business update.]]>https://www.globenewswire.com/news-release/2024/03/27/2853596/0/en/STRATA-Skin-Sciences-Reports-Fourth-Quarter-and-Full-Year-2023-Earnings.html?f=22&fvtc=8&fvtv=PennsylvaniaSTRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 Earnings2024-03-27T20:01:00Z<![CDATA[Company to host conference call and webcast today, March 27, 2024, at 4:30 PM ET Company to host conference call and webcast today, March 27, 2024, at 4:30 PM ET]]>https://www.globenewswire.com/news-release/2024/03/27/2853554/0/en/Universal-Stainless-to-Webcast-Fourth-Quarter-and-Full-Year-2023-Results-Conference-Call-on-March-28th.html?f=22&fvtc=8&fvtv=PennsylvaniaUniversal Stainless to Webcast Fourth Quarter and Full Year 2023 Results Conference Call on March 28th2024-03-27T19:30:00Z<![CDATA[BRIDGEVILLE, Pa., March 27, 2024 (GLOBE NEWSWIRE) -- Universal Stainless & Alloy Products, Inc. (Nasdaq: USAP) announced today that it will report financial results for the fourth quarter and full year 2023 on Thursday, March 28, 2024. In conjunction with the earnings release, the Company will host a conference call at 10:00 a.m. (Eastern) on March 28th. The call will be webcast simultaneously for all interested parties.]]>https://www.globenewswire.com/news-release/2024/03/27/2853365/0/en/WellSpan-Health-Details-Commitment-to-Reimagining-Healthcare-in-its-Annual-Community-Impact-Report.html?f=22&fvtc=8&fvtv=PennsylvaniaWellSpan Health Details Commitment to Reimagining Healthcare in its Annual Community Impact Report2024-03-27T15:04:07Z<![CDATA[York, Pa., March 27, 2024 (GLOBE NEWSWIRE) -- WellSpan Health is committed to taking health care beyond just treatment. With a mission of enhancing health, ensuring lifelong wellness and fostering healthy communities, the impact WellSpan is making in the communities it serves is unmatched. South Central Pennsylvania’s only locally-based and locally-governed health system recently released is annual Community Impact Report, highlighting investments in expansive community programs and outreach, efforts to create a sustainable future, initiatives that are advancing an inclusive culture and improvements made to patient experience and engagement.]]>Community Gardens - Chambersburg, Pa.WellSpan Community Healthhttps://www.globenewswire.com/news-release/2024/03/27/2853358/0/en/Vishay-Intertechnology-FRED-Pt-500-A-Ultrafast-Soft-Recovery-Diode-Modules-in-the-New-TO-244-Gen-III-Package-Deliver-High-Reliability.html?f=22&fvtc=8&fvtv=PennsylvaniaVishay Intertechnology FRED Pt® 500 A Ultrafast Soft Recovery Diode Modules in the New TO-244 Gen III Package Deliver High Reliability2024-03-27T15:00:00Z<![CDATA[Featuring a Common Cathode Configuration, Devices Can Withstand IOL Cycles Up to 5x That of the Previous TO-244 Generation for Improved Life Expectancy While Reducing Losses Featuring a Common Cathode Configuration, Devices Can Withstand IOL Cycles Up to 5x That of the Previous TO-244 Generation for Improved Life Expectancy While Reducing Losses]]>https://www.globenewswire.com/news-release/2024/03/27/2853299/0/en/SHAREHOLDER-ALERT-Barrack-Rodos-Bacine-Notifies-Shareholders-of-Anavex-Life-Sciences-Securities-Class-Action-Lawsuit.html?f=22&fvtc=8&fvtv=PennsylvaniaSHAREHOLDER ALERT: Barrack, Rodos & Bacine Notifies Shareholders of Anavex Life Sciences Securities Class Action Lawsuit2024-03-27T14:00:16Z<![CDATA[PHILADELPHIA, March 27, 2024 (GLOBE NEWSWIRE) -- The law firm of Barrack, Rodos & Bacine announces that a class action lawsuit has been filed on behalf of investors in Anavex Life Sciences Corp. (NASDAQ: AVXL) who purchased the stock between February 1, 2022 and January 1, 2024 (the “Class Period”).]]>https://www.globenewswire.com/news-release/2024/03/27/2853259/0/en/Carmell-Announces-Successful-Closing-of-Axolotl-Biologix-Sale-Transaction.html?f=22&fvtc=8&fvtv=PennsylvaniaCarmell Announces Successful Closing of Axolotl Biologix Sale Transaction2024-03-27T13:15:00Z<![CDATA[PITTSBURGH, March 27, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today announced the successful closing of the previously announced sale of its wholly owned subsidiary, Axolotl Biologix (“AxoBio”) to the initial sellers of AxoBio for 3,845,337 shares of Carmell common stock, 4,243 shares of Carmell preferred stock and cancellation of $8 million in notes payable.]]>https://www.globenewswire.com/news-release/2024/03/27/2853252/0/en/Kessler-Topaz-Meltzer-Check-LLP-Reminds-AMPL-Investors-of-April-15-2024-Deadline-in-Securities-Fraud-Class-Action-against-Amplitude-Inc-AMPL-and-Urges-Investors-to-Contact-The-Firm.html?f=22&fvtc=8&fvtv=PennsylvaniaKessler Topaz Meltzer & Check, LLP Reminds AMPL Investors of April 15, 2024 Deadline in Securities Fraud Class Action against Amplitude, Inc. (AMPL) and Urges Investors to Contact The Firm2024-03-27T13:10:00Z<![CDATA[RADNOR, Pa., March 27, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Amplitude, Inc. (“Amplitude”) (NASDAQ: AMPL). The action charges Amplitude with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects. As a result of Amplitude’ s materially misleading statements and omissions to the public, Amplitude’ s investors have suffered significant losses.]]>https://www.globenewswire.com/news-release/2024/03/27/2853243/0/en/NEXGEL-Reschedules-Fourth-Quarter-and-Full-Year-2023-Financial-Results-Conference-Call-to-Monday-April-1st-at-8-30-a-m-ET-Due-to-Holiday.html?f=22&fvtc=8&fvtv=PennsylvaniaNEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday2024-03-27T13:00:00Z<![CDATA[LANGHORNE, Pa., March 27, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced rescheduling its financial results conference call for the fourth quarter and full year 2023 to Monday, April 1st at 8:30 a.m. ET. The Company intends to file its Form 10-K with the SEC and issue a press release prior to the start of the call.]]>